Drugs that act at more than one target can provide a more effective way of treating complex diseases than the use of target-selective agents. This one-day conference will highlight the relevance of this field to drug discovery, include some successful dual ligand case histories, the lessons learned from past projects and will look into the crystal ball to predict how this field may develop in the years ahead.
Explore
Membership
